{
  "id": 1736438,
  "title": "PBS should fund drug to treat breast cancer, endometriosis and gender dysphoria, experts recommend",
  "url": "https://urgent.news/2026/08/18/pbs-should-fund-drug-to-treat-breast-cancer-endometriosis-and-gender",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-18T15:00:50.000Z",
  "source": {
    "name": "The Guardian Australia",
    "slug": "the-guardian-australia",
    "url": "https://www.theguardian.com/australia-news/2026/aug/18/pbs-breast-cancer-endometriosis-gender-dysphoria-puberty-blocker-drug-triptorelin-ntwnfb"
  },
  "original_language": "en",
  "account": null,
  "summary": "Triptorelin, already listed for prostate cancer, should have unrestricted use, the Pharmaceutical Benefits Advisory Committee says Get our breaking news email , free app or daily news podcast The federal government should fund treatment for thousands of women with breast cancer or endometriosis, and children with gender dysphoria, according to the Pharmaceutical Benefits Scheme’s advisory…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The Guardian",
        "title": "PBS should fund drug to treat breast cancer, endometriosis and gender dysphoria, experts recommend",
        "url": "https://urgent.news/2026/08/18/pbs-should-fund-drug-to-treat-breast-cancer-endometriosis-and-gender-1737639",
        "published": "2026-08-18T15:00:50.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}